Adicet Bio (NASDAQ:ACET) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright restated their neutral rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a research report sent to investors on Thursday, Benzinga reports. Several other research firms have also recently issued reports on ACET. Canaccord Genuity Group decreased their price objective on shares of Adicet Bio from $19.00 to $8.00 and set […]

Leave a Reply

Your email address will not be published.

Previous post Brokers Issue Forecasts for AutoZone, Inc.’s FY2024 Earnings (NYSE:AZO)
Next post Ocado Group’s (OCDO) Not Rated Rating Reiterated at Shore Capital